DE60326382D1 - Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung - Google Patents

Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung

Info

Publication number
DE60326382D1
DE60326382D1 DE60326382T DE60326382T DE60326382D1 DE 60326382 D1 DE60326382 D1 DE 60326382D1 DE 60326382 T DE60326382 T DE 60326382T DE 60326382 T DE60326382 T DE 60326382T DE 60326382 D1 DE60326382 D1 DE 60326382D1
Authority
DE
Germany
Prior art keywords
serum
thiokarbonic
acids
reducing effect
lipid reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326382T
Other languages
German (de)
English (en)
Inventor
Fabio Giannessi
Emanuela Tassoni
Maria Ornella Tinti
Pompeo Pessotto
Uomo Natalina Dell
Anna Floriana Sciarroni
Tiziana Brunetti
Ferdinando Milazzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE60326382D1 publication Critical patent/DE60326382D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
    • C07C53/134—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings monocyclic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60326382T 2002-12-19 2003-12-16 Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung Expired - Lifetime DE60326382D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000629A ITRM20020629A1 (it) 2002-12-19 2002-12-19 Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
PCT/IT2003/000820 WO2004056355A1 (en) 2002-12-19 2003-12-16 USE OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXYCARBOXYLIC ACIDS WITH SERUM-GLUCOSE-LOWERING AND SERUM-LIPID-LOWERING ACTIVITY

Publications (1)

Publication Number Publication Date
DE60326382D1 true DE60326382D1 (de) 2009-04-09

Family

ID=32676886

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326382T Expired - Lifetime DE60326382D1 (de) 2002-12-19 2003-12-16 Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung

Country Status (20)

Country Link
US (1) US7375124B2 (https=)
EP (1) EP1572180B1 (https=)
JP (1) JP2006512362A (https=)
KR (1) KR20050085222A (https=)
CN (1) CN100393309C (https=)
AR (1) AR042547A1 (https=)
AT (1) ATE423558T1 (https=)
AU (1) AU2003288546B8 (https=)
BR (1) BR0317359A (https=)
CA (1) CA2506627A1 (https=)
DE (1) DE60326382D1 (https=)
DK (1) DK1572180T3 (https=)
ES (1) ES2321708T3 (https=)
IT (1) ITRM20020629A1 (https=)
MX (1) MXPA05005848A (https=)
PL (1) PL378414A1 (https=)
PT (1) PT1572180E (https=)
SI (1) SI1572180T1 (https=)
TW (1) TWI308564B (https=)
WO (1) WO2004056355A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045010A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2008092231A1 (en) 2007-02-01 2008-08-07 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
MX2011002448A (es) * 2008-09-05 2011-05-25 Acucela Inc Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos.
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
NZ755378A (en) 2009-03-18 2022-07-29 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
KR20190091564A (ko) 2009-04-22 2019-08-06 리스버로직스 코퍼레이션 신규한 소염제
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة
CN114901641B (zh) * 2020-02-28 2025-06-17 四川科伦博泰生物医药股份有限公司 芳香族化合物及其药物组合物和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
GB1422679A (en) * 1972-11-16 1976-01-28 Funai Pharmaceutical Ind Ltd Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same
FR2285867A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Derives du diphenylsulfoxyde
ITRM20020014A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del

Also Published As

Publication number Publication date
CN1728992A (zh) 2006-02-01
ITRM20020629A1 (it) 2004-06-20
ATE423558T1 (de) 2009-03-15
DK1572180T3 (da) 2009-06-02
AU2003288546B8 (en) 2009-06-11
SI1572180T1 (sl) 2009-06-30
US20060154979A1 (en) 2006-07-13
TWI308564B (en) 2009-04-11
WO2004056355A1 (en) 2004-07-08
EP1572180B1 (en) 2009-02-25
MXPA05005848A (es) 2005-08-26
TW200420531A (en) 2004-10-16
US7375124B2 (en) 2008-05-20
AU2003288546B2 (en) 2009-04-30
CA2506627A1 (en) 2004-07-08
PT1572180E (pt) 2009-05-04
BR0317359A (pt) 2005-11-08
EP1572180A1 (en) 2005-09-14
AR042547A1 (es) 2005-06-22
ES2321708T3 (es) 2009-06-10
AU2003288546A1 (en) 2004-07-14
CN100393309C (zh) 2008-06-11
JP2006512362A (ja) 2006-04-13
KR20050085222A (ko) 2005-08-29
PL378414A1 (pl) 2006-04-03
HK1087007A1 (en) 2006-10-06

Similar Documents

Publication Publication Date Title
DE60326382D1 (de) Verwendung von alpha-phenylthiokarbonsäuren mit serumglucose- und serumlipid-senkender wirkung
ATE426411T1 (de) Neue verwendung von erythropoietin in herzerkrankungen
EP1056883A4 (en) PROTEINS FOR THE PRESENTATION OF THE SURFACE OF A YEAST CELL AND THEIR USES
PL373333A1 (pl) Stosowanie przeciwciał skierowanych przeciw TNFalfa i innego leku
DE50207852D1 (de) Verwendung von fettalkoholethoxylaten als penetrationsförderer
ATE498324T1 (de) Verwendung von säuglingsnahrung mit reduziertem proteingehalt
DE60233825D1 (de) BENZOATESÄURE-2-(a-HYDROXYPENTYL)ESTER UND DESSEN HERSTELLUNG UND VERWENDUNG
EP1357809A4 (en) FOOD PRODUCTS ASEPTISES
EP1480598A4 (en) HANDLING CYTOKINE RATES USING CD83 GENE PRODUCTS
DE502004001052D1 (de) Verwendung von polysilazan zur herstellung von hydrophob- und oleophobmodifizierten oberflächen
EP1499186A4 (en) USE OF HEME-OXYGENASE-1 AND HEME DEGRADATION PRODUCTS
DE60330358D1 (de) Stahlprodukt mit verringerter menge von aluminiumoxid-clustern
IS2694B (is) Hámörkuð tjáning HPV 45 L1 í gersveppi
ATE319437T1 (de) Verwendungen von ppar-gamma-agonisten in neutrophil-verursachten erkrankungen
DE60325967D1 (de) Stimulierung von hämatopoiese bei ex vivo aktivierten immunzellen
DE60317639D1 (de) Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
DE60042552D1 (de) Metabolische manipulation der produktion von aminosäuren
DE60322027D1 (de) Herstellung von defektfreien polyacrylamid-elektrophoresegelen in kunststoffkassetten
ATE399076T1 (de) Herstellung und verwendung von mehrkarbidmaterialien
DE60335623D1 (de) Komponenten von absorbierenden wegwerfartikeln mit gedruckten blöcken
DE60203923D1 (de) Verwendung von cmc in fleischverarbeitungsprodukten
DE10256898A8 (de) Elektrochemischer Nachweis von Nukleinsäuren
ATE423569T1 (de) Verwendung von hitzelabilem escherichia-coli- toxin als adjuvans bei geflügel
EE05325B1 (et) Orgaano-mineraalv„etis ja selle valmistamise meetod
ATE405288T1 (de) Selektion von eimeriastämmen in geflügel über extraintestinale sporozoiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition